X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (241) 241
humans (208) 208
male (160) 160
female (152) 152
gastroenterology & hepatology (147) 147
middle aged (134) 134
adult (121) 121
aged (79) 79
liver (64) 64
transplantation (63) 63
treatment outcome (58) 58
liver transplantation (54) 54
liver diseases (50) 50
surgery (50) 50
cirrhosis (45) 45
analysis (40) 40
gastroenterology and hepatology (35) 35
liver cirrhosis (34) 34
risk factors (34) 34
prognosis (33) 33
abridged index medicus (30) 30
animals (28) 28
diagnosis (28) 28
adolescent (26) 26
mortality (26) 26
patients (26) 26
management (25) 25
prospective studies (25) 25
survival (25) 25
follow-up studies (24) 24
hepatitis c (24) 24
retrospective studies (24) 24
care and treatment (23) 23
time factors (22) 22
aged, 80 and over (21) 21
hypertension (21) 21
infection (21) 21
therapy (21) 21
young adult (21) 21
rats (20) 20
antiviral agents - therapeutic use (19) 19
hepatitis c, chronic - drug therapy (19) 19
genotype (18) 18
health aspects (18) 18
hepacivirus - genetics (18) 18
medical research (18) 18
portal hypertension (18) 18
biopsy (17) 17
drug therapy, combination (17) 17
hepatitis (17) 17
medicine, experimental (17) 17
belgium (16) 16
hepatitis c virus (16) 16
immunology (16) 16
portal-hypertension (16) 16
disease (15) 15
hepatocellular-carcinoma (15) 15
inflammation (15) 15
clinical trials (14) 14
gene expression (14) 14
interferon (14) 14
liver cirrhosis - complications (14) 14
predictive value of tests (14) 14
rodents (14) 14
fibrosis (13) 13
hepatocellular carcinoma (13) 13
hepatology (13) 13
immunohistochemistry (13) 13
prevalence (13) 13
radiology, nuclear medicine & medical imaging (13) 13
recipients (13) 13
sensitivity and specificity (13) 13
transplants & implants (13) 13
dose-response relationship, drug (12) 12
europe (12) 12
immunosuppressive agents - therapeutic use (12) 12
liver - pathology (12) 12
liver failure (12) 12
liver transplantation - adverse effects (12) 12
multivariate analysis (12) 12
recurrence (12) 12
research (12) 12
risk (12) 12
risk-factors (12) 12
transplantation of organs, tissues, etc (12) 12
treatment (12) 12
child (11) 11
drug therapy (11) 11
hepatitis c, chronic - virology (11) 11
kaplan-meier estimate (11) 11
kidney-disease (11) 11
liver cirrhosis - surgery (11) 11
reproducibility of results (11) 11
ribavirin (11) 11
studies (11) 11
tumors (11) 11
virology (11) 11
cholangitis (10) 10
cytokines (10) 10
double-blind (10) 10
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
世界胃肠病学杂志:英文版, ISSN 1007-9327, 2017, Volume 23, Issue 30, pp. 5499 - 5507
AIM To develop a MRI-based method for accurate determination of liver volume(LV) and to explore the effect of long-term everolimus(EVR) treatment on LV in PCK... 
mTOR inhibitor | Somatostatin analogue | Magnetic resonance imaging | Fibrocystic liver disease | Liver volume measurement | KIDNEY-DISEASE | VOLUME | liver volume measurement | somatostatin analogue | INDIVIDUAL PATIENT DATA | MTOR | INHIBITION | SOMATOSTATIN | PCK RAT MODEL | POOLED ANALYSIS | GASTROENTEROLOGY & HEPATOLOGY | PROGRESSION | SIROLIMUS | Cysts - drug therapy | Liver - pathology | Phosphorylation | TOR Serine-Threonine Kinases - metabolism | Humans | Liver Diseases - pathology | Liver Diseases - diagnostic imaging | Gene Expression Profiling | Phosphatidylinositol 3-Kinases - metabolism | Hypertension, Portal - prevention & control | TOR Serine-Threonine Kinases - antagonists & inhibitors | Liver Cirrhosis - diagnostic imaging | Liver - drug effects | Liver - diagnostic imaging | Everolimus - therapeutic use | Female | Drug Evaluation, Preclinical | Proto-Oncogene Proteins c-akt - metabolism | Real-Time Polymerase Chain Reaction | Disease Models, Animal | Liver Cirrhosis - drug therapy | Somatostatin - analogs & derivatives | Rats | Random Allocation | Cysts - pathology | Magnetic Resonance Imaging | Animals | Signal Transduction - drug effects | Cysts - diagnostic imaging | Ribosomal Protein S6 - metabolism | Liver Cirrhosis - pathology | Peptides, Cyclic - therapeutic use | Liver Diseases - drug therapy | Somatostatin - therapeutic use | Index Medicus | Basic Study
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2017, Volume 66, Issue 4, pp. 680 - 681
Verbeke et al discuss the Farnesoid X receptor (FXR) has been identified as a master regulator of bile acid homeostasis, with endogenous bile acids serving as... 
Gastroenterology and Hepatology | Animal models | Liver diseases | Bile acids | Antiinflammatory agents | Liver | Homeostasis | Reabsorption | Inflammation | Chemical modification | Acids | Intestine | Fibrosis | Chenodeoxycholic acid | Cholestasis | Bile | Steroids | Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2010, Volume 362, Issue 25, pp. 2370 - 2379
Journal Article
Journal of Hepatology, ISSN 0168-8278, 12/2018, Volume 69, Issue 6, pp. 1215 - 1216
An obituary for Prof Jan De Groote, who passed away at aged 93, is presented. De Groote will be remembered as the first Secretary General of EASL (1966-1969)... 
GASTROENTEROLOGY & HEPATOLOGY | College professors | Deaths | Liver
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2011, Volume 364, Issue 25, pp. 2417 - 2428
In patients with HCV infection who did not have a sustained response to peginterferon plus ribavirin, the addition of telaprevir to this combination therapy... 
MEDICINE, GENERAL & INTERNAL | GENOTYPE 1 INFECTION | BOCEPREVIR | RIBAVIRIN | PEGINTERFERON ALPHA-2A | HEPATITIS-C | Recurrence | Humans | Middle Aged | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Polyethylene Glycols - adverse effects | Male | RNA, Viral - blood | Recombinant Proteins | Oligopeptides - adverse effects | Polyethylene Glycols - therapeutic use | Viral Load | Oligopeptides - therapeutic use | Serine Proteinase Inhibitors - therapeutic use | Young Adult | Serine Proteinase Inhibitors - adverse effects | Adult | Female | Drug Therapy, Combination | Hepacivirus - isolation & purification | Double-Blind Method | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Genotype | Logistic Models | Hepatitis C, Chronic - drug therapy | Sequence Analysis, DNA | Retreatment | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Aged | Interferon-alpha - adverse effects | Peginterferon alfa-2a | Patient outcomes | Genetic aspects | Hepatitis C | Drug therapy | Comparative analysis | Health aspects | Liver diseases | Cytokines | Leukopenia | Anemia | Infections | Ribonucleic acid--RNA | Ribavirin | Manuscripts | Genotype & phenotype | Consent | Interferon | Drug dosages | Genotypes | Neutropenia | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2016, Volume 375, Issue 7, pp. 631 - 643
In this 12-month, placebo-controlled trial involving patients with primary biliary cholangitis who had an inadequate response to ursodiol, treatment with... 
CHANGING NOMENCLATURE | PBC | FXR | MEDICINE, GENERAL & INTERNAL | URSODEOXYCHOLIC ACID | PROGNOSIS | CIRRHOSIS | CHOLESTATIC PRURITUS | NONALCOHOLIC STEATOHEPATITIS | BIOCHEMICAL RESPONSE | SCALE | Liver Cirrhosis - etiology | Bile Acids and Salts - blood | Double-Blind Method | Humans | Middle Aged | Liver Cirrhosis, Biliary - drug therapy | Male | Chenodeoxycholic Acid - analogs & derivatives | Bone Density - drug effects | Chenodeoxycholic Acid - adverse effects | Fibroblast Growth Factors - blood | Chenodeoxycholic Acid - therapeutic use | Adult | Female | Aged | Liver Cirrhosis, Biliary - complications | Liver Cirrhosis, Biliary - blood | Alkaline Phosphatase - blood | Pruritus - chemically induced | Clinical trials | Ursodiol | Care and treatment | Usage | Dosage and administration | Cholangitis | Primary biliary cirrhosis | Alkaline phosphatase | Liver diseases | Syngeneic grafts | Liver | Bilirubin | Pruritus | Phosphatase | Patients | Cirrhosis | Allografts | Acids | Fibrosis | Drug therapy | Bile | Liver transplantation | Index Medicus | Abridged Index Medicus | Alkaline Phosphatase | Chenodeoxycholic Acid | Fibroblast Growth Factors | Gastroenterology and Hepatology | Bone Density | drug therapy | chemically induced | complications | Gastroenterologi | drug effects | Liver Cirrhosis | blood | Bile Acids and Salts | etiology | Biliary | analogs & derivatives | adverse effects | therapeutic use
Journal Article
Journal Article
Gut, ISSN 0017-5749, 11/2010, Volume 59, Issue 11, pp. 1561 - 1569
Journal Article